Sagimet Biosciences Inc. (10)

Browse by Contract Category

Contracts

Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated December 21, 2020 (Filed With SEC on April 16, 2021)
2007 Equity Incentive Plan (Filed With SEC on April 16, 2021)
Form of Indemnification Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on April 16, 2021)
Exclusive License and Development Agreement by and between the Registrant and Ascletis BioScience Co. Ltd., dated as of January 18, 2019 (Filed With SEC on April 16, 2021)
Lease Agreement by and between the Registrant and Casiopea Bovet, LLC, dated as of March 1, 2019 (Filed With SEC on April 16, 2021)
Amended and Restated Nominating Agreement, dated as of April 15, 2021, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on April 16, 2021)
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the 2007 Equity Incentive Plan (Filed With SEC on April 16, 2021)
Sagimet Biosciences Inc. 2017 Equity Incentive Plan (Filed With SEC on April 16, 2021)
Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Sagimet Biosciences Inc. 2017 Equity Incentive Plan (Filed With SEC on April 16, 2021)
Patent Assignment Agreement by and between the Registrant and Gannex Pharma Co., Ltd., dated as of October 25, 2019 (Filed With SEC on April 16, 2021)